Agency Links:   Home  Contact Us   Help   Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating
Cancer Drug Manual
Drug Index (Professional)
User's Guide to the Cancer Drug Manual
Acitretin
Aldesleukin
Alemtuzumab
Amifostine
Amsacrine
Anagrelide
Anastrozole
Asparaginase
Azacitidine
BCG
Bendamustine
Bevacizumab
Bexarotene
Bicalutamide
Bleomycin
Bortezomib
Bromocriptine
Buserelin
Busulfan
Cabergoline
Capecitabine
Carboplatin
Carmustine
Cetuximab
Chlorambucil
Cisplatin
Cladribine
Clodronate
Cyclophosphamide
Cyproterone
Cytarabine
Dacarbazine
Dactinomycin
Dasatinib
Daunorubicin
Dexamethasone
Dexrazoxane
Docetaxel
Doxorubicin
Doxorubicin, pegylated liposomal
Epirubicin
Erlotinib
Estramustine
Etoposide
Exemestane
Filgrastim
Fludarabine
Fluorouracil
Flutamide
Fulvestrant
Gefitinib
Gemcitabine
Goserelin
Hydroxyurea
Ibritumomab
Idarubicin
Ifosfamide
Imatinib
Interferon alfa-2b
Irinotecan
Ixabepilone
Lanreotide
Lapatinib
Lenalidomide
Letrozole
Leucovorin
Leuprolide
Lomustine
Mechlorethamine
Medroxyprogesterone
Megestrol
Melphalan
Mercaptopurine
Mesna
Methotrexate
Mitomycin
Mitotane
Mitoxantrone
Nilutamide
Nilotinib
Octreotide
Oxaliplatin
Paclitaxel
Paclitaxel nanoparticle, albumin-bound (nab)
Pamidronate
Panitumumab
Pemetrexed
Porfimer
Procarbazine
Raltitrexed
Rituximab
Sorafenib
Streptozocin
Sunitinib
Tamoxifen
Temozolomide
Temsirolimus
Teniposide
Testosterone
Thalidomide
Thioguanine
Thiotepa
Thyrotropin alfa
Topotecan
Tositumomab
Trastuzumab
Treosulfan
Tretinoin
Vinblastine
Vincristine
Sorafenib
Vinorelbine

Alemtuzumab

SYNONYM(S): Campath, Ldp 103, Mabcambath, MabCampath-1H

COMMON TRADE NAME(S): MABCAMPATH®

CLASSIFICATION: monoclonal antibody, cytotoxic1

PDF version
The BC Cancer Agency is a part of the Provincial Health Services Authority .
If you notice a problem with this page, please report it via the Bug Report Form.
Copyright © 2010. BC Cancer Agency. All Rights Reserved. | Terms of Use | Privacy

Unofficial document if printed. Please refer to the following web address for up-to-date information: http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/alemtuzumab.htm